Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shared insights on. Cramer discussed the company stock in ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Johnson & Johnson moved to dismiss an amended, proposed class action alleging the company engaged in fraudulent transfers to cheat talc litigation plaintiffs of recoveries.

We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Johnson & Johnson (NYSE:JNJ) is ...

Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer ...

Following a third failed bankruptcy maneuver by Johnson& Johnson, trial lawyers with Dallas- based Nachawati Law Group have filed three new lawsuits on behalf of women who developed cancer after ...

In February, Johnson & Johnson was ordered to pay $72 million to the family of a woman died of ovarian cancer linked to the company's talc-based powders. Still, Johnson & Johnson maintains the ...

The company faces over 60,000 claims from individuals alleging its baby powder caused ovarian cancer. Following the ruling, JNJ's stock fell to $157.11, moving it about 6 percent below a key ...

The lawsuit by the company, Oral Cancer Prevention International Inc., claims J&J worried that consumers might link Listerine with oral cancer, a disease that affects 30,000 Americans every year ...

Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails Provided by Business Wire May 15, 2025, 9:48:00 PM.

Nachawati Law Group represents thousands of women nationwide who developed ovarian cancer after using Johnson’s Baby Powder and other talc-based products that internal company documents have ...